Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Hyperbaric Oxygen Treatment of Mandibular Osteoradionecrosis. A Randomized Clinical Study
This study is currently recruiting participants.
Verified by University of Copenhagen, September 2008
Sponsored by: University of Copenhagen
Information provided by: University of Copenhagen
ClinicalTrials.gov Identifier: NCT00760682
  Purpose

There is currently not sufficient evidence that hyperbaric oxygen (HBO) benefits the surgical removal of necrotic bone in osteoradionecrosis patients. This study aims at testing the hypothesis that HBO does improve healing after surgical removal of necrotic bone in irradiated previous head and neck cancer patients compared to not receiving HBO.


Condition Intervention Phase
Osteoradionecrosis
Procedure: Hyperbaric oxygen
Phase II

U.S. FDA Resources
Study Type: Interventional
Study Design: Treatment, Randomized, Open Label, Parallel Assignment, Efficacy Study
Official Title: Hyperbaric Oxygen Treatment of Mandibular Osteoradionecrosis. A Randomized Clinical Study

Further study details as provided by University of Copenhagen:

Primary Outcome Measures:
  • CTCAE v 3.0 criteria [ Time Frame: 1 year ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Life Quality Body Mass Index Pain intensity Trismus Xerostomia Dysphagia Dental status [ Time Frame: 1 year ] [ Designated as safety issue: No ]

Estimated Enrollment: 114
Study Start Date: June 2008
Estimated Study Completion Date: April 2011
Estimated Primary Completion Date: April 2011 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
1: Experimental
30 preoperative HBO sessions, sequestrectomy and 10 postoperative HBO sessions. The duration of each session is 90 minutes. 100 % oxygen is inhaled during decompression to 2.4 ATA.
Procedure: Hyperbaric oxygen
30 preoperative and 10 postoperative HBO sessions 90 minutes each. Sequestrectomy is performed after 30 sessions.
2: No Intervention
Sequestrectomy without HBO treatment

  Show Detailed Description

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Osteoradionecrosis grade 2, 3 or 4 according to the CTCAE v 3.0 criteria
  • Localized to the mandibula
  • > 18 yrs old

Exclusion Criteria:

  • Existing malignant disease
  • Previous HBO
  • Pregnancy or lactation
  • Uncontrollable claustrophobia
  • Undrained pneumothorax
  • Blood pressure > 220/110
  • Exposed titanium reconstruction device
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00760682

Contacts
Contact: Lone Forner, DDS; PhD +45 35 45 82 11 lone.forner@rh.regionh.dk
Contact: Erik Jansen, MD, DMSc +45 35 45 12 57 erik.jansen@rh.regionh.dk

Locations
Denmark
Department of Anaesthesia, Copenhagen University Hospital Recruiting
Copenhagen, Denmark, 2100
Contact: Lone Forner, DDS, PhD     +45 35 45 82 11     lone.forner@rh.regionh.dk    
Contact: Erik Jansen, MD, DMSc     +45 35 45 12 57     erik.jansen@rh.regionh.dk    
Principal Investigator: Lone Forner, DDS, PhD            
Sponsors and Collaborators
University of Copenhagen
Investigators
Principal Investigator: Lone Forner, DDS, PhD Copenhagen Trial Unit, Center for Clinical Intervention Research
  More Information

Related Info  This link exits the ClinicalTrials.gov site

Responsible Party: Copenhagen University Hospital ( Lone Forner, DDS, PhD )
Study ID Numbers: DAHANCA 21
Study First Received: September 25, 2008
Last Updated: September 25, 2008
ClinicalTrials.gov Identifier: NCT00760682  
Health Authority: Denmark: Danish Medicines Agency

Keywords provided by University of Copenhagen:
osteoradionecrosis
hyperbaric oxygen
sequestrectomy

Study placed in the following topic categories:
Wounds and Injuries
Disorders of Environmental Origin
Osteoradionecrosis
Radiation Injuries

ClinicalTrials.gov processed this record on January 14, 2009